年間契約型資訊服務
商品編碼
1455820
Top300 Bio CDMO:設施索引和生物製造商註冊資料庫Top 300 Bio CDMO - Facility Index and Biomanufacturers Subscription Database |
該資料庫是世界上唯一一個積極追蹤400 多家提供生物製藥開發和製造服務的公司的 CDMO 設施的合約開發和製造設施資料庫。
全球有數百家工廠以臨床和商業規模生產生物製劑,到 2023 年,它們總共將產生 168.9 億美元的服務收入,每年增長 17%。
該資料庫基於30 年的生物製藥和生命科學行業評估和基準,不斷更新以包含全面的資訊和見解。
"Top300 Bio CDMO 設施指數" 對每個 "專用" CDMO 設施進行排名,並按區域提供生物製造區域/柵格的定量分析。
The only Global Contract Development and Manufacturing Facilities Database subscription that actively tracks over 400+ dedicated CDMO facilities providing development and manufacturing services for biopharmaceuticals.
Hundreds of facilities manufacturing clinical and commercial scale biologics, account for $16.89 billion in services sales in 2023, growing at 17% annually.
Based on 30 years of evaluating and benchmarking the biopharmaceutical and life sciences industry, this database is updated continually and includes comprehensive information and insights.
"Top300 Bio CDMO Facility Index" ranks each 'dedicated' CDMO facility and provides regional quantitative analysis of biomanufacturing regions and clusters.